Inari Medical, Inc. (NARI)

NASDAQ: NARI · IEX Real-Time Price · USD
56.37
-0.72 (-1.26%)
At close: Feb 26, 2024, 4:00 PM
56.00
-0.37 (-0.66%)
Pre-market: Feb 27, 2024, 7:26 AM EST
-1.26%
Market Cap 3.21B
Revenue (ttm) 469.31M
Net Income (ttm) -2.77M
Shares Out 57.59M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 101
Open 56.97
Previous Close 57.09
Day's Range 55.45 - 57.45
52-Week Range 47.81 - 71.85
Beta 0.93
Analysts Buy
Price Target 78.83 (+39.84%)
Earnings Date Feb 28, 2024

About NARI

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex veno... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date May 22, 2020
Employees 1,100
Stock Exchange NASDAQ
Ticker Symbol NARI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for NARI stock is "Buy." The 12-month stock price forecast is $78.83, which is an increase of 39.84% from the latest price.

Price Target
$78.83
(39.84% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

12 days ago - GlobeNewsWire

5 medical stocks growing earnings by triple digits

While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that the f...

Other symbols: ARGXAXSMAZTAVCEL
20 days ago - MarketBeat

Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

7 weeks ago - GlobeNewsWire

OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

ALISO VIEJO, Calif. , Jan. 8, 2024 /PRNewswire/ -- Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular ...

7 weeks ago - PRNewsWire

Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suf...

2 months ago - GlobeNewsWire

Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)

Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally Clinical study randomizing up to 1,200 patien...

3 months ago - GlobeNewsWire

Inari Medical Closes Acquisition of LimFlow

IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

3 months ago - GlobeNewsWire

Insider Buys: Lumen, Air Products, Inari, Remitly and Sarepta

Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m.

Other symbols: APDRELYSRPTLUMN
3 months ago - CNBC Television

Inari Medical to Present at Upcoming Investor Conferences

IRVINE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

4 months ago - GlobeNewsWire

LimFlow Announces Agreement to Be Acquired by Inari Medical

PARIS & SAN JOSE, Calif.--(BUSINESS WIRE)-- #generalsurgery--LimFlow announces an agreement to be acquired by Inari Medical.

4 months ago - Business Wire

Inari Medical Reports Third Quarter 2023 Financial Results

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

4 months ago - GlobeNewsWire

Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif.

4 months ago - GlobeNewsWire

Inari Medical to Announce Third Quarter 2023 Financial Results

IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

4 months ago - GlobeNewsWire

Inari Medical Reports Second Quarter 2023 Financial Results

IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

7 months ago - GlobeNewsWire

Inari Medical to Present at the 43rd Annual Canaccord Growth Conference

IRVINE, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

7 months ago - GlobeNewsWire

Inari Medical to Announce Second Quarter 2023 Financial Results

IRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

8 months ago - GlobeNewsWire

Inari Medical Announces the Release of 2022 Ethos and Sustainability Report

IRVINE, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venou...

9 months ago - GlobeNewsWire

Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous...

10 months ago - GlobeNewsWire

Inari Medical Reports First Quarter 2023 Financial Results

IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venou...

10 months ago - GlobeNewsWire

Inari Medical to Present at the Bank of America 2023 Healthcare Conference

IRVINE, Calif., May 02, 2023 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

10 months ago - GlobeNewsWire

Inari Medical to Announce First Quarter 2023 Financial Results

IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ven...

11 months ago - GlobeNewsWire

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from veno...

1 year ago - GlobeNewsWire

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

1 year ago - GlobeNewsWire

Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

1 year ago - GlobeNewsWire

Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

IRVINE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from veno...

1 year ago - GlobeNewsWire